Menu

Image of the Day: Coral on Acid

Researchers exposed a coral reef to carbonated water to study the effects of ocean acidification.

Mar 16, 2018
The Scientist Staff, The Scientist Staff

A healthy coral reef community at One Tree Island in Australia's Great Barrier ReefDAVID KLINE

The growth of coral reefs will be severely reduced by the end of the 21st century if carbon emissions aren’t decreased, according to a study published Wednesday (March 14) in Nature. Researchers exposed a 400-square-meter coral community in the Great Barrier Reef to seawater with artificially elevated carbon dioxide levels for 30 days. The elevated CO2 increased the acidity of the seawater, changing it from a normal pH of 8.1 to one of about 6.1, similar to the level that is projected to occur by the end of this century if carbon emissions remain unchecked. They found that coral growth—measured as net community calcification—was reduced by 34% in the exposed reef compared to controls.

“Our findings provide strong evidence that ocean acidification caused by carbon dioxide emissions will severely slow coral reef growth in the future unless we make steep and rapid reductions in greenhouse gas emissions,” says coauthor Rebecca Albright, an invertebrate zoologist at California Academy of Sciences, in a statement.

R. Albright et al., “Carbon dioxide addition to coral reef waters suppresses net community calcification,” Nature, doi:10.1038/nature25968, 2018.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.